Topics
A to Z
Data &
 Statistics
Forms &
Publications
News &
Advisories
Licensing &
Certification
Rules &
Regulations
Public Health
Directory

Respiratory Syncytial Virus (RSV)


Subscribe to receive email alerts for the weekly RSV report

  • Respiratory syncytial virus (RSV) is the most common cause of severe lower respiratory infection among infants and young children.
  • Symptoms of illness include fever, runny nose, cough and wheezing. When children are first infected with RSV, 25-40% of them will have symptoms of bronchiolitis or pneumonia and up to 2% of children will require hospitalization.
  • In addition to infants who are premature, low birth weight, or with congenital or chronic cardiopulmonary disease, most susceptible are infants from 2 to 4 months when maternal antibodies drop off. By the second year of life, about 90% of children will have been exposed to RSV.
  • No vaccine or effective therapy is available for RSV. Infants and children at risk for severe RSV infection can receive immune prophylaxis with monthly doses of a humanized murine anti-RSV monoclonal antibody during the RSV season.


Disease Reporting

Oregon and Southwest Washington RSV Surveillance

SRV is not a mandated disease for reporting incidence. Oregon follows the CDC definition for onset and offset.  Please see surveillance data for more information.


Data

See other surveillance data for more information.


See Also


Go SearchRespiratory Syncytial Virus (RSV) search results